About me:
I completed my Bachelor’s and Master’s degrees in Natural Sciences at the University of Cambridge, specialising in Biochemistry. During my Master’s research, I designed and developed multifunctional NK cell engagers to target cancers. I started my PhD in the Genomic Variation and Disease Group at the LMS in 2025, where I aim to characterise the immunogenicity of tumour neoantigens to identify immunotherapeutic targets under the co-supervision of Lila Allou and Petter Brodin.
The genomic variation and disease team at the LMS started in 2024. Led by Lila Allou, it aims to understand the molecular consequences of SVs affecting noncoding regions in development and disease, thereby improving rare disease diagnosis and identifying potential therapeutic targets in cancer.